1.Expression of main protein antigen of Helicobacter pylori and serum antibody in infected patients.
Chinese Journal of Epidemiology 2004;25(9):820-820
Antibodies, Bacterial
;
blood
;
Antigens, Bacterial
;
biosynthesis
;
Bacterial Proteins
;
biosynthesis
;
Carrier Proteins
;
biosynthesis
;
Gastritis
;
microbiology
;
Helicobacter Infections
;
immunology
;
Helicobacter pylori
;
immunology
;
isolation & purification
;
Humans
;
Recombinant Proteins
;
biosynthesis
2.Purification and characterization of recombinant human anti-HAV monoclonal antibody.
Jing-Shuang WEI ; Ran TAO ; Wei-Wei SUN ; Qia JIA ; Chuan LI ; Mi-Fang LIANG
Chinese Journal of Biotechnology 2004;20(2):257-261
In order to obviate the drawbacks of plasma immunoglobulins, the whole molecular recombinant human anti-HAV (hepatitis A virus) monoclonal antibody (anti-HAV IgG) produced and secreted by rCHO cells was purified and its physicochemical properties were extensively characterized. The rCHO cells were cultured in serum-free medium and the supernatants were collected. The recombinant human IgG molecules were sequentially purified by ultrafiltration, rProtein A Sepharose Fast Flow affinity chromatography, ion exchange chromatography and diafiltration. In affinity chromatography, prior to the target protein elution, an intermediate high salt wash step was inserted, different pH and salt concentrations were evaluated for the capacity of removing host cell DNA. The yield of the downstream purification process was approximately 40%. The purity of anti-HAV IgG thus generated was assayed with SEC-HPLC method, integration result showed that the monomeric IgG content was more than 99%. Western-blot was carried out with AP-antiHuman IgG (Fab specific) and AP-antiHuman IgG (Fc specific) respectively, the blot result demonstrated that the anti-HAV IgG is human antibody with Fab and Fc structure. The specific anti-HAV activity determined by ELISA was 100 IU/mg, with anti-HAV immunoglobulin as the working standard reference. Ligand leakage in the eluate of the affinity column was approximately 32 ng/mg IgG, while after further purification steps, it was decreased to less than 2 ng/mg IgG. Residual host cell DNA was monitored with solid dot blot assay, DNA can be removed effectively with intermediate high salt wash step in the affinity chromatography. Free sulfhydryl content of anti-HAV IgG was assayed with fluorescent spectrophotometer, the low molecular weight bands appeared in non-reducing SDS-PAGE may be caused by the presence of free sulfhydryl. The endotoxin content was less than 1EU/ mg examined by standard LAL test procedures. Anti-HAV IgG prepared with this process is able to fulfill the regulatory requirements of State Food and Drug Administration for recombinant products.
Antibodies, Monoclonal
;
biosynthesis
;
immunology
;
isolation & purification
;
Chromatography, Affinity
;
methods
;
Hepatitis A Antibodies
;
biosynthesis
;
immunology
;
isolation & purification
;
Hepatitis A virus
;
immunology
;
Humans
;
Immunoglobulin G
;
biosynthesis
;
immunology
;
isolation & purification
;
Recombinant Proteins
;
biosynthesis
;
immunology
;
isolation & purification
3.Purification of recombinant lysostaphin by monoclonal antibody affinity chromatography.
Jinjiang HUANG ; Hongyu WU ; Jien ZHANG ; Qingshan HUANG
Chinese Journal of Biotechnology 2009;25(1):147-151
Lysostaphin, a specific endopeptidase enzyme derived from Staphylococcus aureus, is a bactericidal agent against Staphylococcus and difficult to be drug-resistant. This study established the monoclonal antibody affinity chromatography to obtain lysostaphin of high purity for drug-use standard. The purified Lysostaphin was of > 95% purity and its recovery rate more than 90%. Moreover, the affinity column kept its efficiency of purification invariable after more than 30 times repeat. Also, the dye release assay validated that the purified lysostaphin had significant bactericidal activity. This method was simple and of high efficacy for the lysostaphin purification and showed its potency in commercial production.
Antibodies, Monoclonal
;
immunology
;
Chromatography, Affinity
;
methods
;
Lysostaphin
;
biosynthesis
;
isolation & purification
;
Recombinant Proteins
;
biosynthesis
;
isolation & purification
;
Staphylococcus aureus
;
enzymology
4.Production of recombinant humanized anti-HBsAg Fab antibody by fermentation.
Ning DENG ; Jun-Jian XIANG ; Wen-Yin CHEN ; Sheng XIONG ; Xun-Zhang WANG ; Kuan-Yuan SU
Chinese Journal of Biotechnology 2004;20(5):800-804
In order to produce recombinant human anti-HBsAg Fab antibody in Pichia pastoris, the recombinant yeast was fermented using fed-batch system in a 30 L bioreactor. The fermentation temperature was 30 degrees C, the pH was 5.0 approximately 5.3, and the DO was 20% approximately 30%. The recombinant Fab antibody was purified from crude culture supernatant by ion exchange and analyzed by SDS-PAGE and western blot and ELISA. When the absorbance (OD600) of broth reach 300 at the end of fed-batch phase, the induced phase was initiated. The results showed that recombinant human anti-HBsAg Fab antibody was high-level expressed in recombinant Pichia pastoris using a fed-batch fermentation system. Both chains of the Fab were successfully expressed upon methanol induction. After 192 h of induction, the expression level of recombinant Fab (soluble) reached 412 mg/L. The recombinant Fab antibody was purified effectively by ion-exchange chromatography from the fermentation supernatant to a purity of 95%. And the affinity activities of the purified recombinant Fab antibdy and fermentation supernatant were detected, and both of them showed high affinity activities. The results demonstrated that recombinant human anti-HBsAg Fab antibody could be high level produced by fed-batch fermentations in Pichia pastoris. Which can be efficiently used in industrial production.
Fermentation
;
Hepatitis B Antibodies
;
biosynthesis
;
isolation & purification
;
Hepatitis B Surface Antigens
;
immunology
;
Humans
;
Immunoglobulin Fab Fragments
;
biosynthesis
;
isolation & purification
;
Pichia
;
genetics
;
Recombinant Proteins
;
biosynthesis
;
isolation & purification
5.Prokaryotic expression, purification of human LINGO-1(aa76-319) and preparation of its polyclonal antibody.
Jun LV ; Xin LU ; Xiao-Dan JIANG ; Chang-Chen HU ; Ying-Qian CAI ; Mou-Xuan DU ; Yu-Xi ZOU ; Ling-Sha QIN
Journal of Southern Medical University 2009;29(11):2175-2178
OBJECTIVETo express and purify the fusion protein of extracellular domain of human Ig domain-containing, neurite outgrowth inhibitor (Nogo) receptor-interacting protein-1 (LINGO-1(aa76-319)) in prokaryotic cells and prepare the rabbit anti-LINGO-1 polyclonal antibody (pAb).
METHODSThe 732 bp DNA sequence of hLINGO-1(aa76-319) was obtained from pCMV-SPORT6 by PCR and inserted into pET30a(+) plasmid to construct the prokaryotic expression plasmid pET30a(+)-hLINGO-1(aa76-319), which was subsequently transformed into E.coli. The target fusion protein was expressed with IPTG induction and purified by Ni(2+)-NTA affinity chromatography column. The antiserum against hLINGO-1(aa76-319) was obtained from the rabbits immunized with hLINGO-1(aa76-319), and the titer of the pAb was determined using enzyme linked immunosorbent assay (ELISA) and its specificity identified using Western blotting.
RESULTSThe prokaryotic expression plasmid pET30a(+)-hLINGO-1(aa76-319) was constructed successfully. Efficient expression of the target fusion protein was achieved with IPTG induction at the optimal concentration of 0.4 mmol/L and culture temperature at 37 degrees celsius; for 2.5 h. The hLINGO-1(aa76-319) fusion protein was effectively expressed in E.coli as inclusion bodies, and the soluble protein was obtained through denaturation and refolding procedures, and the purified fusion protein showed a purity above 90%. The titer of the anti-hLINGO-1(aa76-319) pAb obtained by immunizing the rabbits with the purified protein reached 1:1.6x10(6), and Western blotting confirmed its good specificity.
CONCLUSIONThe fusion protein hLINGO-1(aa76-319) with high purity has been obtained and the anti-hLINGO-1(aa76-319) pAb obtained shows a high titer and good specificity, which provide important experimental basis for further functional investigation of LINGO-1.
Animals ; Antibodies ; immunology ; isolation & purification ; Antibody Specificity ; Escherichia coli ; genetics ; metabolism ; Humans ; Immune Sera ; immunology ; Membrane Proteins ; biosynthesis ; genetics ; immunology ; Nerve Tissue Proteins ; biosynthesis ; genetics ; immunology ; Plasmids ; genetics ; Rabbits ; Recombinant Fusion Proteins ; biosynthesis ; genetics ; immunology
6.Expression, purification and immunogenicity analysis of HPV type 18 virus-like particles from Escherichia coli.
Minghui XIE ; Shaowei LI ; Wentong SHEN ; Zhongyi LI ; Yudi ZHUANG ; Xiaobing MO ; Ying GU ; Ting WU ; Jun ZHANG ; Ningshao XIA
Chinese Journal of Biotechnology 2009;25(7):1082-1087
Here, we presented a method to bacterially express the major structural protein L1 of Human Papillomavirus type 18 (HPV18) as soluble form. We found that the purified L1 could self-assemble to virus-like particles (VLPs). Further, we investigated the immunogenicity and the induced level of neutralizing antibody using these VLPs. First, the genome of HPV18 was cloned from a patient in Xiamen. It was used as template for PCR amplification of HPV18 L1 gene. The resultant DNA fragment was inserted into expression vector pTrxFus and expressed in Escherichia coli GI724. Second, L1 protein was purified by ammonium sulfate precipitation, ion-exchange chromatography and hydrophobic interaction chromatography; and the purified L1 was subjected to self-assembly to form VLPs with the removal of premixed reductant DTT. Finally, the size and morphology of these VLPs was investigated by Dynamic Light Scattering and Transmission Electronic Microscopy as 29.34 nm in hydrated radius and globular particles similar with native HPV18. The half effective dosage (ED50) and maximum level of neutralizing antibody elicitation were measured by vaccinations on mice, rabbit and goat using pseudovirus neutralization cell model. The results showed that the ED50 of HPV18 VLPs is 0.006 microg in mice, and the maximum titer of neutralizing antibody elicited in rabbit and goat is up to 10(7). As a conclusion, we can provide HPV18 VLPs with highly immunogenicity from prokaryote expression system, which may pave a new way for research and development of prophylactic vaccine for HPV18.
Animals
;
Capsid Proteins
;
biosynthesis
;
genetics
;
immunology
;
Escherichia coli
;
genetics
;
metabolism
;
Goats
;
Human papillomavirus 18
;
immunology
;
isolation & purification
;
Mice
;
Oncogene Proteins, Viral
;
biosynthesis
;
genetics
;
immunology
;
Rabbits
;
Recombinant Proteins
;
biosynthesis
;
genetics
;
immunology
;
Virion
;
genetics
;
immunology
7.Preparation and characterization the polyclonal antibody of the nonstructural protein of human highly pathogenic H5N1 avian influenza viruses.
Pei-Yu JIANG ; Hui-Lian HUANG ; Hong-Chang ZHOU ; Bo-Ying XU ; Fu-Ping GU ; Li-Shan MIN ; Jing ZHONG ; Li-Cheng DAI
Chinese Journal of Experimental and Clinical Virology 2013;27(2):138-140
OBJECTIVEOf this study was to prepare high sensitivity and high specificity of highly pathogenic H5N1 subtype avian influenza virus NS1 protein antibody and a preliminary assessment of its potency.
METHODSConstruct pET-28a (+) recombinant vector containing the H5N1 subtype of avian influenza virus NS1 sequences of E. coli BL21 (DE3), induced expression of NS1 protein, NS1 recombinant protein was obtained by Ni-NTA column purified by affinity chromatography, and SDS-PAGE and Western Blot analysis. Purified protein antigen to immunize New Zealand white rabbits, obtained rabbit anti-NS1 serum, affinity-purified polyclonal antibodies. Using ELISA and Western Blot analysis of purified antibody titer and specificity.
RESULTSNS1 fusion protein was highly expressed in a purity of greater than 90%, with the fusion protein was used to immunize New Zealand white rabbits anti-NS1 polyclonal antibody titer of 1:80 000, and specific recognition of the H5N1 subtype of avian influenza virus NS1 protein.
CONCLUSIONSNS1 polyclonal antibodies to NS1 recombinant protein purified antigen, with better potency and specificity, and to prepare the conditions for the development of the H5N1 subtype of avian influenza virus detection kit.
Animals ; Antibodies, Viral ; biosynthesis ; immunology ; Escherichia coli ; genetics ; Influenza A Virus, H5N1 Subtype ; immunology ; Rabbits ; Recombinant Fusion Proteins ; immunology ; isolation & purification ; Viral Nonstructural Proteins ; genetics ; immunology
8.Preparation of the monoclonal antibody against human Bocavirus VP2 protein.
Zhi-Hui ZHAO ; Peng-Hao XUE ; Jian-Min WEI ; Qian ZHANG ; Wen-Zhi ZHENG ; Fen-Lian MA ; Wu-Mei YUAN ; Li-Shu ZHENG
Chinese Journal of Experimental and Clinical Virology 2012;26(1):63-65
OBJECTIVETo express and purify HBoV VP2 protein, and the monoclonal antibody against HBoV VP2 protein was prepared with hybridoma technique.
METHODSThe HBoV VP2 cloned into vector pET-30a was expressed in E. coil. After purified by immobilized metal affinity chromatography, the BALB/c mouse was immunized with purified protein as antigen. The positive hybridoma cells were screened with hybridoma technique and ELISA assay. Isotype and titer of the monoclonal antibody were detected.
RESULTSThe recombinant HBoV VP2 protein was expressed and purified, and then the monoclonal antibody was obtained with hybridoma technique. The titer of the IgG monoclonal antibody was up to 1:4 x 10(5).
CONCLUSIONMonoclonal antibody against recombinant HBoV VP2 protein was prepared and the antibody titer was high. This work may provide a new method in rapid diagnosis and study of HBoV.
Animals ; Antibodies, Monoclonal ; immunology ; Capsid Proteins ; genetics ; immunology ; Human bocavirus ; immunology ; Hybridomas ; Mice ; Mice, Inbred BALB C ; Plasmids ; Recombinant Proteins ; biosynthesis ; immunology ; isolation & purification
9.Expression and purification of GST-CML28 fusion protein and preparation of its polyclonal antibody.
Xia MAO ; Bing ZHANG ; Xue-Ling BAI ; Long-Long LIU ; Dong-Hua ZHANG
Journal of Experimental Hematology 2012;20(6):1302-1306
This study was aimed to investigate the expression of GST-CML28 in Escherichia Coli and to prepare its antibody. The constructed recombinant expression vectors CML28-pGEX-3X were transformed into Escherichia Coli BL21 under IPTG induction. The protein was abstracted from the transformers, and purified by a GSTrap FF column. The rabbits were immunized by the purified fusion protein to produce serum with anti-CML28 antibody. The serum was purified by chromatographic column stuffed with glutathione Sephamse 4B to get the antibody. The specific antibody against CML28 was further identified by ELISA, Western blot, immunohistochemistry and quantum dot luminescence. The results indicated that GST-CML28 fusion protein was expressed in Escherichia coli and its specific polyclonal antibody was obtained. It is concluded that the anti-CML28 polyclonal antibodies with high titer and specificity are successfully prepared. These antibodies provide an useful experimental tool to profoundly research the physiological significance and biological function of the CML28 gene.
Animals
;
Antibodies
;
immunology
;
isolation & purification
;
metabolism
;
Antigens, Neoplasm
;
biosynthesis
;
immunology
;
isolation & purification
;
Cells, Cultured
;
Escherichia coli
;
metabolism
;
Exosome Multienzyme Ribonuclease Complex
;
biosynthesis
;
immunology
;
isolation & purification
;
Genetic Vectors
;
Glutathione Transferase
;
biosynthesis
;
isolation & purification
;
Human Umbilical Vein Endothelial Cells
;
cytology
;
Humans
;
RNA-Binding Proteins
;
biosynthesis
;
immunology
;
isolation & purification
;
Rabbits
;
Recombinant Fusion Proteins
;
biosynthesis
;
immunology
;
isolation & purification
10.Establishment of purification procedure for recombinant fusion protein B7-2-PE40KDEL.
Hai-Rong GUAN ; Yu-Ying SUN ; Zhi-Hong YUAN ; Hui-Li ZHANG ; Fei LIANG ; Nan LIU ; Si-Qi GUO ; Cai-Xia XI ; Yong-Zhi XI
Journal of Experimental Hematology 2006;14(1):123-127
This study was aimed to establish downstream purification procedure by which the protein of interest can be purified to higher purity rapidly and efficiently. The different combinations of various purification strategies, methods and conditions were compared, including reversed phase chromatography, metal chelating chromatography, anion exchange chromatography, blue dye affinity chromatography, filtration chromatography and so on. The results showed that in reversed phase chromatography, isolated protein of interest was denatured and precipitated immediately after chromatography because methanol or acetonitrile were adopted as the organic phase. In blue dye affinity chromatography expecting to purify the protein of interest in one step, protein of interest was difficultly differentiated from mixed protein as much proteins bound to the chromatography media by non-specific affinity. While there is a translation-enhancing sequence T7-g10 in the PRSETA-B7-2-PE40KDEL expression vector, so it adds 6 histidines to the N terminus of the protein of interest, this allows to purify the protein of interest by metal chelating chromatography. Based on this characteristic, a three-step chromatography line including metal chelating chromatography, anion exchange chromatography and filtration chromatography was finally established after repeated experiments. By this way the purity of protein of interest reached 95% and the total recovery rate was 8%. The result of Western blot indicated that the expressed and purified recombinant B7-2-PE40KDEL could specifically bind with mAb against human B7-2 and multiple antibody against PEA. The cytotoxicity of the recombinant toxin tested by MTT method showed that the B7-2-PE40KDEL could selectively kill Jurkat cell line expressing CD28 receptor well and had no killing effect on the Raji cell line unexpressing CD28 receptor. It is concluded that a high efficient and speedy three-step purification procedure for the purifying recombinant protein B7-2-PE40KDEL was established, and this procedure possess selective killing activity on CD28 positive T lymphocytes.
B7-2 Antigen
;
biosynthesis
;
genetics
;
Bacterial Proteins
;
biosynthesis
;
genetics
;
CD28 Antigens
;
immunology
;
Cloning, Molecular
;
Escherichia coli
;
genetics
;
Gene Expression
;
Humans
;
Recombinant Fusion Proteins
;
biosynthesis
;
genetics
;
isolation & purification